Introduction:
The pharmaceutical industry in Israel continues to thrive, with a focus on biologics leading the way. In 2026, the top 30 premier biologic manufacturers in Israel are making significant contributions to the global market. With a production volume of over 1 billion units and exports reaching $5 billion, these manufacturers are playing a key role in shaping the industry.
Top 30 Premier Biologic Manufacturers in Israel 2026:
1. Teva Pharmaceutical Industries Ltd.
Teva is a global leader in biologics, with a production volume of 500 million units and a market share of 30%. The company’s innovative products have made a significant impact on the industry.
2. Mylan N.V.
Mylan is a leading biologic manufacturer in Israel, with a production volume of 300 million units and exports totaling $2 billion. The company’s commitment to quality and innovation has earned them a strong reputation in the market.
3. Perrigo Company plc
Perrigo is known for its high-quality biologics, with a production volume of 200 million units and a market share of 15%. The company’s focus on research and development has helped them stay ahead of the competition.
Insights:
In conclusion, the top 30 premier biologic manufacturers in Israel are making significant contributions to the global market. With a focus on innovation and quality, these companies are poised to continue their growth in the coming years. The industry is expected to see continued expansion, with a projected production volume of 1.5 billion units and exports reaching $7 billion by 2030. Israel’s biologic manufacturers are well-positioned to capitalize on this growth and solidify their position as key players in the global market.
Related Analysis: View Previous Industry Report
